Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Sales rise for Novartis

January 30, 2014 Sales and Marketing Gleevec, Glivec, Novartis, gilenya, q4, sales

Multiple sclerosis drug Gilenya, with sales rising 62% year-on-year to $1.9 billion, was one of the stars of last year …
News

GSK halts chickenpox vaccines over quality concerns

January 29, 2014 Manufacturing and Production, Sales and Marketing Boostrix-Polio, GSK, Varilrix, chickenpox, vaccines

GlaxoSmithKline has suspended worldwide distribution of two chickenpox vaccines after production standards were not met at one of its facilities …
News

Profits drop for Pfizer

January 29, 2014 Sales and Marketing Enbrel, Lipitor, Pfizer, Spiriva, Zoetis, q4

Pfizer’s turnover fell to $54.6 billion in 2013, a 6% drop year-on-year from $54.7 billion in 2012, but the group …
News

High-dose Copaxone the right medicine for Teva

January 29, 2014 Research and Development, Sales and Marketing Biogen, Copaxone, FDA, MS, Mylan, Teva

The FDA has approved a high-dose version of Teva’s multiple sclerosis drug Copaxone which will help the firm offset approaching …
News

Merck KGaA head jumping ship to Lanxess

January 29, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck, Merck KGaA, lanxess, zachert

Merck KGaA’s chief financial officer Matthias Zachert is exiting the firm in order to fulfill a chief executive appointment at …
Appointment

Servier signs cancer partnership

January 29, 2014 Research and Development, Sales and Marketing AbbVie, Servier, breast cancer, curie

Servier has extended by three years its deal with leading research group Curie-Cancer to identify therapeutic targets for treating triple-negative …
News

Pfizer lung cancer drug suffers late-stage setback

January 28, 2014 Research and Development, Sales and Marketing Cancer, NSCLC, Pfizer, Roche, Tarceva, dacomitinib

An experimental cancer drug developed by Pfizer has failed in two separate Phase III clinical studies. Dacomitinib is a tyrosine …
News

NICE looks at Xtandi again

January 28, 2014 Sales and Marketing Astellas, NHS, NICE, Xtandi

NICE has announced it is to consult again on its decision to recommend Astellas Pharma’s prostate cancer drug Xtandi after …
News

Targacept appoints chairman

January 28, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targacept, richard

Clinical-stage biopharma firm Targecept has appointed its non-executive director since 2002 John Richard to be its chairman of the board. …
Appointment

NICE rejects ‘benefit’ test

January 28, 2014 Sales and Marketing Dillon, EMIG, NHS, NICE, benefits

NICE has refused to include a ‘wider societal benefit’ test into its deliberations about which drugs should be available on …
News

J&J: we’re proud to top social media leaderboard

January 27, 2014 Medical Communications, Sales and Marketing IMS, J&J, JJ, Janssen, digital, epatient, pharma

Johnson & Johnson says recognising the rise of the ePatient and being willing to share its corporate plans with the …
News

BMS revenue drops in 2013

January 27, 2014 Sales and Marketing AZ, BMS, Yervoy, diabetes, hep C, q4

Bristol-Myers’ Squibb’s revenue has fallen 7% year-on-year to $16.4 billion during 2013. Turnover rose 6% to $4.4 billion in the …
News

Teva’s Great White Hope knocked back by Europe

January 27, 2014 Sales and Marketing CHMP, EU, MS, Nerventra, Teva

The drug designed to be a follow-up to Teva’s wildly successful Copaxone has been hit by rejection in Europe, leaving …
News

NHS reform: did the government get it right?

January 27, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DH, Hunt, Lansley, NHS, atkins, reform, reforms

Some nine months after the coalition government’s controversial health reforms came in, have they been a success? And how are …
Feature

PTC Therapeutics makes series of changes

January 27, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PTC Therapeutics

Biopharma firm PTC Therapeutics has expanded its senior management team with a raft of appointments. Robert Spiegel (pictured) becomes its …
Appointment
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026